MYELOFIBROSIS，MF
Clinical trials for MYELOFIBROSIS，MF explained in plain language.
Never miss a new study
Get alerted when new MYELOFIBROSIS，MF trials appear
Sign up with your email to follow new studies for MYELOFIBROSIS，MF, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a Dual-Action pill tame bone marrow tumors?
Disease control TerminatedThis phase 1 trial is testing an experimental pill called flonoltinib maleate in people with certain bone marrow tumors, including myelofibrosis, polycythemia vera, and essential thrombocythemia. The drug targets two proteins involved in abnormal blood cell growth. The study aims…
Matched conditions: MYELOFIBROSIS，MF
Phase: PHASE1 • Sponsor: Guizhou Bailing Group Pharmaceutical Co Ltd • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New hope for rare blood cancer: drug duo targets enlarged spleen
Disease control OngoingThis study tests whether adding the experimental drug navitoclax to the standard drug ruxolitinib can shrink the spleen and reduce symptoms better than other available treatments in adults with myelofibrosis that has returned or not improved. About 330 participants will be random…
Matched conditions: MYELOFIBROSIS，MF
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC